Tyler-Stone Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-88
Closed -$47.7K 479
2024
Q2
$47.7K Hold
88
0.02% 370
2024
Q1
$45.6K Hold
88
0.02% 376
2023
Q4
$41.5K Hold
88
0.02% 384
2023
Q3
$38K Hold
88
0.02% 379
2023
Q2
$39K Buy
+88
New +$40.6K 0.02% 375
2022
Q4
$45K Hold
88
0.03% 337
2022
Q3
$40K Hold
88
0.03% 332
2022
Q2
$42K Hold
88
0.03% 342
2022
Q1
$43K Hold
88
0.02% 354
2021
Q4
$41K Buy
+88
New +$37K 0.02% 384

Other funds holding ELV

Tyler-Stone Wealth Management's ELV Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 88 shares — an estimated $47.7K sold.

Tyler-Stone Wealth Management first reported a position in ELV in Q4 2021 and held it in 10 quarters. The position peaked at $47.7K in Q2 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 88 Elevance Health shares in Q3 2024, an estimated $47.7K.
  • Tyler-Stone Wealth Management first reported a position in Elevance Health in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Elevance Health position peaked at $47.7K in Q2 2024.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.